Literature DB >> 34091819

Cluster Headache is Still Lurking in the Shadows.

Paolo Martelletti1,2, Martina Curto3,4,5.   

Abstract

Cluster headache, apart from its legendary reputation as the most violent headache that can exist, suffers from an average 60-month delay in diagnosis. The simplicity of the clinical manifestations, although dramatic, makes this delay inexplicable. The education of emergency department physicians and various specialists not specifically dedicated to headaches allows cluster headache to remain in a lurking position with flourishing periods of disease that are often unpredictable in both onset and disappearance. Older drugs have always shown high efficacy but also an equally high rate of adverse events, often discouraging their appropriate use. The availability of a new drug class such as monoclonal antibodies for calcitonin gene-related peptide or its receptor (CGRP(r)), which have already been efficient for migraine, shows a jeopardized geography of access in the world, and this favors the progression of the episodic form into chronic and of the chronic into refractory.

Entities:  

Keywords:  Calcitonin gene-related peptide; Cluster headache; Education; Galcanezumab; Refractory chronic cluster headache; Verapamil

Year:  2021        PMID: 34091819     DOI: 10.1007/s40122-021-00278-5

Source DB:  PubMed          Journal:  Pain Ther


  24 in total

1.  Sickness absence and disability pension days in patients with cluster headache and matched references.

Authors:  Christina Sjöstrand; Kristina Alexanderson; Pontus Josefsson; Anna Steinberg
Journal:  Neurology       Date:  2020-02-05       Impact factor: 9.910

Review 2.  Epidemiology and genetics of cluster headache.

Authors:  Michael Bjørn Russell
Journal:  Lancet Neurol       Date:  2004-05       Impact factor: 44.182

Review 3.  Cluster headache pathophysiology - insights from current and emerging treatments.

Authors:  Diana Y Wei; Peter J Goadsby
Journal:  Nat Rev Neurol       Date:  2021-03-29       Impact factor: 42.937

4.  Tackling the perils of unawareness: the cluster headache case.

Authors:  Giorgio Lambru; Anna P Andreou; Elena Ruiz de la Torre; Paolo Martelletti
Journal:  J Headache Pain       Date:  2017-04-27       Impact factor: 7.277

5.  The impact of remission and coexisting migraine on anxiety and depression in cluster headache.

Authors:  Byung-Su Kim; Pil-Wook Chung; Byung-Kun Kim; Mi Ji Lee; Jeong Wook Park; Min Kyung Chu; Jin-Young Ahn; Dae Woong Bae; Tae-Jin Song; Jong-Hee Sohn; Kyungmi Oh; Daeyoung Kim; Jae-Moon Kim; Soo-Kyoung Kim; Yun-Ju Choi; Jae Myun Chung; Heui-Soo Moon; Chin-Sang Chung; Kwang-Yeol Park; Soo-Jin Cho
Journal:  J Headache Pain       Date:  2020-05-29       Impact factor: 7.277

6.  Migraine and cluster headache show impaired neurosteroids patterns.

Authors:  Angela Koverech; Claudia Cicione; Luana Lionetto; Marta Maestri; Francesco Passariello; Elisabetta Sabbatini; Matilde Capi; Cristiano Maria De Marco; Martina Guglielmetti; Andrea Negro; Luisa Di Menna; Maurizio Simmaco; Ferdinando Nicoletti; Paolo Martelletti
Journal:  J Headache Pain       Date:  2019-05-27       Impact factor: 7.277

Review 7.  Current Understanding of the Chronobiology of Cluster Headache and the Role of Sleep in Its Management.

Authors:  Mads Barloese
Journal:  Nat Sci Sleep       Date:  2021-02-11

8.  Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?

Authors:  Messoud Ashina; Paolo Martelletti
Journal:  J Headache Pain       Date:  2018-05-08       Impact factor: 7.277

Review 9.  Migraine and cluster headache - the common link.

Authors:  Anne Luise Vollesen; Silvia Benemei; Francesca Cortese; Alejandro Labastida-Ramírez; Francesca Marchese; Lanfranco Pellesi; Michele Romoli; Messoud Ashina; Christian Lampl
Journal:  J Headache Pain       Date:  2018-09-21       Impact factor: 7.277

10.  Prevalence of familial cluster headache: a systematic review and meta-analysis.

Authors:  Emer O'Connor; Benjamin S Simpson; Henry Houlden; Jana Vandrovcova; Manjit Matharu
Journal:  J Headache Pain       Date:  2020-04-25       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.